Impact of socioeconomic deprivation on screening for cardiovascular disease risk in a primary prevention population: a cross-sectional study. by Lang, SJ et al.
Impact of socioeconomic deprivation
on screening for cardiovascular disease
risk in a primary prevention population:
a cross-sectional study
Sarah-Jane Lang,1 Gary A Abel,2 Jonathan Mant,1 Ricky Mullis1
To cite: Lang S-J, Abel GA,
Mant J, et al. Impact of
socioeconomic deprivation
on screening for
cardiovascular disease risk in
a primary prevention
population: a cross-sectional
study. BMJ Open 2016;6:
e009984. doi:10.1136/
bmjopen-2015-009984
▸ Prepublication history and
additional material is
available. To view please visit
the journal (http://dx.doi.org/
10.1136/bmjopen-2015-
009984).
Received 13 September 2015
Revised 22 October 2015
Accepted 16 November 2015
1General Practice & Primary
Care Research Unit,
University of Cambridge,
Cambridge, UK
2Cambridge Centre for Health
Services Research, University
of Cambridge, Cambridge,
UK
Correspondence to
Dr Ricky Mullis;
rm582@medschl.cam.ac.uk
ABSTRACT
Objectives: Investigate the association between
socioeconomic deprivation and completeness of
cardiovascular disease (CVD) risk factor recording in
primary care, uptake of screening in people with
incomplete risk factor recording and with actual CVD
risk within the screened subgroup.
Design: Cross-sectional study.
Setting: Nine UK general practices.
Participants: 7987 people aged 50–74 years with no
CVD diagnosis.
Methods: CVD risk was estimated using the
Framingham equation from data extracted from
primary care electronic health records. Where
there was insufficient information to calculate risk,
patients were invited to attend a screening
assessment.
Analysis: Proportion of patients for whom clinical
data were sufficiently complete to enable CVD risk to
be calculated; proportion of patients invited to
screening who attended; proportion of patients who
attended screening whose 10-year risk of a
cardiovascular event was high (>20%). For each
outcome, a set of logistic regression models were run.
Crude and adjusted ORs were estimated for person-
level deprivation, age, gender and smoking status. We
included practice-level deprivation as a continuous
variable and practice as a random effect to account for
clustering.
Results: People who had lower Indices of Multiple
Deprivation (IMD) scores (less deprived) had
significantly worse routine CVD risk factor recording
(adjusted OR 0.97 (0.95 to 1.00) per IMD decile;
p=0.042). Screening attendance was poorer in those
with more deprivation (adjusted OR 0.89 (0.86 to 0.91)
per IMD decile; p<0.001). Among those who attended
screening, the most deprived were more likely to have
CVD risk >20% (OR 1.09 (1.03 to 1.15) per IMD
decile; p=0.004).
Conclusions: Our data suggest that those who had
the most to gain from screening were least likely to
attend, potentially exacerbating existing health
inequalities. Future research should focus on tailoring
the delivery of CVD screening to ensure engagement of
socioeconomically deprived groups.
BACKGROUND
Cardiovascular disease (CVD) remains the
leading cause of mortality worldwide1 and
the second greatest cause of death in the
UK.2 CVD is a major contributor to health
inequalities, with a greater prevalence of
CVD risk factors, incidence of events, poorer
outcomes and premature death in people in
lower socioeconomic groups. Despite an
overall decline in CVD mortality, socio-
economic inequalities persist.3 Between 2010
and 2012, those living in the most deprived
local authority4 were three times more likely
to die prematurely of CVD compared with
the most afﬂuent.2 The cause of this health
inequality is multifaceted and not completely
explained by the higher burden of classical
CVD risk factors.5 Cultural inﬂuences
leading to poorer access to healthcare and
suboptimal primary prevention management
could contribute to the higher incidence of
CVD in deprived groups. Currently, little evi-
dence exists on the association between
sociodemographic factors and routine CVD
risk factor recording in primary care in the
primary prevention population.
Modiﬁable risk factors for developing CVD
such as elevated blood pressure (BP), serum
cholesterol concentration and smoking have
been shown to respond to pharmacological
Strengths and limitations of this study
▪ The study population represented all national
Indices of Multiple Deprivation (IMD) deciles.
▪ Screening was administered and performed by
research staff, reducing potential bias.
▪ The Framingham equation can underestimate
cardiovascular disease (CVD) risk in the most
deprived groups.
▪ Ethnicity could not be taken into account owing
to incomplete recording in the medical records.
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and behavioural interventions in primary6 7 and second-
ary prevention of CVD. In 2009 in England, the
National Health Service (NHS) Health Check pro-
gramme was introduced for all people aged 40–74 years
with no history of CVD or diabetes, with the aim of iden-
tifying those with previously unrecognised CVD risk and
reducing health inequalities.8 9 However, the impact of
such a programme is dependent on uptake by those
invited to attend and on the extent to which preventive
treatments are applied in people identiﬁed as being at
risk. Evidence from cervical,10 breast,11 colorectal12 and
diabetic retinopathy13 screening demonstrates that socio-
economic deprivation is associated with lower levels of
participation. Ensuring equitable uptake, or even target-
ing particularly those who are currently disadvantaged
in terms of healthcare, is essential if these health
inequalities are to be reduced, as inequitable attendance
at screening has the potential to widen existing
inequalities.14
This study examines the ﬁndings from a research-led
programme of screening for CVD risk introduced across
one socioeconomically diverse region of the UK. The
aim of this study was to investigate whether socio-
economic deprivation is associated with completeness of
routine CVD risk factor recording in primary care, with
uptake of screening in people with incomplete risk
factor recording and with actual CVD risk within the
screened subgroup.
METHODS
Data collection
Anonymised data were extracted from the primary care
electronic health records of all patients aged between 50
and 74 years registered for over 12 months at nine
general practices across the West Midlands area of the
UK. Practices were purposefully selected to represent dif-
ferent practice sizes and levels of socioeconomic depriv-
ation determined by the Indices of Multiple Deprivation
(IMD) score of the practice area. All data queries were
run between October 2008 and June 2009 using
MIQUEST software. Extracted data included demo-
graphic information, cardiovascular risk factor details
and records of prescribed medication (BP-lowering or
cholesterol-lowering therapy). Patients who had pre-
existing CVD recorded were excluded. The presence of
cardiovascular risk factor details was deﬁned as a
non-zero value for BP and/or total or high-density lipo-
protein (HDL) serum cholesterol in a value ﬁeld along-
side a read code for BP or total cholesterol recorded
within the previous 5 years. We chose this time cut-off to
reﬂect the recommended repeat frequency of the NHS
Health Checks (every 5 years). All cholesterol-lowering
and BP-lowering medication prescription data within the
previous 90 days were extracted.
CVD risk was estimated using the Framingham equa-
tion, as recommended by the National Institute for
Health and Care Excellence (NICE) at the time of data
collection.15 This uses age, sex, BP, total/HDL choles-
terol ratio, smoking status and existence of diabetes
and/or left ventricular hypertrophy to estimate an indivi-
dual’s 10-year risk of having a cardiovascular event.16
CVD risk scores were adjusted by a factor of 1.4 or 1.5,
respectively, for patients of South Asian origin or with a
family history of premature cardiovascular events.15
Those with no recorded ethnicity were assumed not to
be South Asian, and those with no recorded family
history were assumed to have no family history of CVD.
Those already receiving some form of preventive
therapy were assumed to have been previously identiﬁed
as high risk. Patients with diabetes were classiﬁed as high
risk if they had at least one other recorded CVD risk
factor.
Where there was insufﬁcient clinical information to
calculate CVD risk, patients were invited by letter to
attend their practice for a screening assessment of their
risk, with one reminder sent to non-responders 2 weeks
later. A short covering letter that brieﬂy summarised
the study in a variety of languages and encouraged
patients to speak to someone who can help them
understand the study information was included with the
invitation.
The screening assessment was carried out between
January 2009 and May 2010 by research nurses at the
patient’s surgery. This included assessment of:
▸ Systolic and diastolic BP measurements
▸ Serum cholesterol (including total, HDL and low-
density lipoprotein (LDL)), glucose and creatinine
▸ Medical history, including questions relating to CVD
risk factors, existing CVD disease, family history of
CVD and ethnicity
▸ Height and weight and calculated body mass index
▸ Ten-year CVD risk using the Framingham equation
Where patients were identiﬁed as being at high cardio-
vascular risk (ie, over 20% 10-year risk), the practice was
informed. Further treatment was at the discretion of the
general practitioner (GP).
Statistical analyses
Three outcomes were explored. First, the proportion of
patients for whom CVD risk factor recording was sufﬁ-
ciently complete to enable CVD risk to be calculated
(without interpolation for missing data). Second, the
proportion of patients invited to screening who
attended. Third, the proportion of patients (restricted
to those who attended a screening clinic) whose 10-year
risk of having a cardiovascular event was high (above
20%) or low (20% or below).
For each outcome, a set of logistic regression models
were run. In each case, the exposure of interest was
person-level deprivation as deﬁned by 2010 IMD deciles
which were derived from whole country data and then
applied to our dataset. In order to maximise power, this
exposure was treated as a continuous variable taking
integer values between 1 (least deprived national IMD
decile) and 10 (most deprived national IMD decile). By
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using IMD decile as a continuous variable (rather than
the underlying IMD score), we respect the rank-based
interpretation of IMD while increasing power by assum-
ing a linear relationship. For each model, departure for
linearity was tested using a quadratic term; however, this
was not signiﬁcant in any models, so we present the
simple linear versions here. As a sensitivity analysis, we
also estimated models using a categorical version of
patients’ IMD which relaxed the linear relationship
assumption. First, crude ORs were estimated from a
logistic regression model with only a single exposure
variable. This was done for deprivation as well as age
group, gender and smoking status. As our prime interest
was in deprivation, we also included a continuous vari-
able for practice-level deprivation17 operationalised in
the same way as individual deprivation and describing
the deprivation of all patients attending the practice,
rather than that of the patient. Following the crude ana-
lysis, adjusted ORs were estimated from a mixed-effects
logistic regression including all variables described
above. Practice was further included as a random effect
(intercept) to account for clustering of individuals
within the same practice. Analyses were restricted to
patients with complete data for all covariates. Using the
adjusted models, we estimate an OR comparing patients
from the most deprived deciles with those from the least
deprived deciles. As there are nine intervals between the
most and least deprived deciles, the OR comparing
them is equal to the OR for a single decile change
raised to the power of nine. As a comparison, we also
use the variance of the random effect to estimate an OR
comparing those attending practices at the top and
bottom (or mid) of the 95% reference range of prac-
tices. Essentially, this compares the range of practice
inﬂuence (ignoring extreme practices).
Ethnicity was poorly coded, with 57% missing data,
and was therefore not included in the original model-
ling. To determine whether this variable would inﬂuence
the model, we ran a sensitivity analysis including com-
plete case ethnicity codes. This had no signiﬁcant effect
on the strength of associations found within the model.
Data were analysed using Stata V.13.1 (StataCorp,
Texas, USA).
RESULTS
Figure 1 depicts the number of patients identiﬁed from
the nine general practices, the numbers included and
the reasons for exclusion from each phase of the ana-
lyses. From the nine general practices involved, a total of
7987 people were included in the primary prevention
analysis. Of these, 5466 (68%) had insufﬁcient routinely
collected clinical data to be able to calculate risk of
CVD. All of these were invited to a screening clinic, of
which 2321 (42%) attended, and 852 (37%) were subse-
quently found to be at high risk.
The mean age of the study population was 60 years,
with approximately equal numbers of males and females
(table 1). The distribution within each IMD decile was
not uniform, with an excess of people in the most
deprived decile and under-representation of people in
some of the less deprived deciles.
A higher proportion of people in the two least
deprived deciles had insufﬁcient data in their records to
allow a risk score to be calculated (ﬁgure 2).
People with higher IMD scores (more deprived) were
less likely to attend the screening clinic when invited
(ﬁgure 3). However, of those who did attend, people
with higher IMD scores were more likely to be at high
risk of CVD.
Figure 1 Flow chart depicting the number of patients identified from the nine general practices, the numbers included and the
reasons for exclusion from each phase of the analyses.
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Older people, non-smokers and those with higher IMD
scores (more deprived) had signiﬁcantly better CVD risk
factor data recording in general practice (table 2).
Of those invited to screening, females, non-smokers
and the less deprived were more likely to attend
(table 3).
Of those who attended the screening clinic, it was the
most deprived who were found to be most likely to be at
>20% 10-year risk of CVD after adjusting for age, gender
and smoking status (which are included in the
Framingham risk score calculation). Practice IMD was
not associated with CVD risk at screening, but there was
a signiﬁcant random effect of practice (table 4).
We also compared the most deprived deciles with the
least deprived deciles of the cohort. In terms of patients
who had insufﬁcient data to calculate a CVD risk score,
there is a relatively modest effect of deprivation but not
one small enough to be ignored (most vs least deprived
decile OR (95% CI) 0.78 (0.62 to 0.99); p=0.042). The
effect of deprivation was most dramatic for attendance
at screening (most vs least deprived decile OR (95% CI)
0.34 (0.26 to 0.44); p<0.001). A substantial effect of
deprivation was also seen for being at >20% 10-year risk
of CVD among those screened, although, as noted
above, in the opposite direction (most vs least deprived
decile OR (95% CI) 2.12 (1.28 to 3.53); p<0.001). These
estimates are broadly consistent with those achieved
using a categorical variable for IMD (see online supple-
mentary material S1). For all three outcomes, the effect
of practice was substantial. Our estimate of ORs compar-
ing practices at the top and bottom of the 95% refer-
ence range was 3.16 (95% CI 1.99 to 6.88, p<0.001) for
having insufﬁcient data to calculate a CVD risk, 4.00
(95% CI 2.19 to 11.63, p<0.001) for attendance at
screening and 2.09 (95% CI 1.38 to 5.45, p=0.017).
Thus, in the cases of being unable to calculate risk or
attending screening, the effect of which practice a
patient attended was potentially larger than the effect of
deprivation.
DISCUSSION
Summary of findings
Just over two-thirds of people at potentially high risk of
developing CVD are not being routinely proﬁled in
primary care when the opportunity arises, and within
this group, there are differences related to socio-
economic deprivation. We found risk factor recording
was better in older people, non-smokers and in people
who were more deprived. The latter two results are sur-
prising, in that one would have anticipated smokers to
be more likely to have had their cardiovascular risk
assessed. The higher recording in people who were most
deprived may in part reﬂect the higher incidence of
existing CVD and diabetes in these people. When
people with insufﬁcient risk factor data in their records
were invited for screening, the less deprived were more
likely to attend screening. Females and non-smokers
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were also more likely to attend screening. Of those who
did attend screening, it was the most deprived who were
most likely to be at high CVD risk. Therefore, our data
suggest that those who potentially had the most to gain
from the screening intervention were the least likely to
take up the offer. It is also of note that which practice a
patient attended had a strong inﬂuence of whether risk
factors were recorded, whether invitees attended screen-
ing and the subsequently estimated risk.
Comparison with existing literature
The few existing studies available support our ﬁndings
that CVD risk recording, without the presence of an
organised screening programme, is better in those
Figure 2 Proportion of the
primary prevention population for
whom a CVD risk score could not
be calculated (without
interpolation) owing to incomplete
clinical data. (IMD decile 1=least
deprived, IMD decile 10=most
deprived.) CVD, cardiovascular
disease; IMD, Indices of Multiple
Deprivation.
Figure 3 The percentage of the invited population who attended screening and the proportion of these found to be at high risk
of CVD at the screening clinic. (IMD decile 1=least deprived, IMD decile 10=most deprived.) CVD, cardiovascular disease; IMD,
Indices of Multiple Deprivation.
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subgroups that are at inherently higher risk, that is, the
older and more deprived.18 19 However, this appears to
be the ﬁrst paper to demonstrate that being a smoker is
associated with poorer routine CVD risk recording.
Artac et al18 assessed CVD risk factor recording prior to
the implementation of the NHS Health Checks in an
ethnically diverse primary care trust (PCT) in west
London and found risk factor recording to be better in
the most deprived patient group and BP and cholesterol
recording to be better in older patients. This is consist-
ent with the ﬁndings presented here using national IMD
deciles to account for deprivation, which are potentially
more representative of the national spectrum of depriv-
ation compared with the local IMD tertiles used by Artac
et al. Artac et al18 found that risk factor recording was
better in women, which was not evident here. In
addition, Artac et al18 were better able to examine the
effect of ethnicity (78% data complete) on CVD risk
factor recording, whereas here (43% data complete),
this was not something that could be examined with
conﬁdence.
The existing literature on determinants of attendance
at CVD screening is inconclusive. The literature can be
divided into those that evaluate local screening pro-
grammes often set up as part of a research study, such as
in this paper, and those that evaluate national externally
implemented screening programmes, such as the NHS
Health Checks.
Comparison with local screening programmes
Attendance at CVD screening is variable between coun-
tries and within the UK, ranging from 18%20 to 92%.21
Table 2 OR of association of IMD and other variables on having insufficient data to calculate a CVD risk score
Not able to calculate CVD risk due to incomplete data
(n=7987) Crude OR (95% CI) p Value Adjusted OR (95% CI) p Value
IMD (per decile) 0.97 (0.95 to 0.98) <0.001 0.97 (0.95 to 1.00) 0.042
Age
50–54 Reference <0.001 Reference <0.001
55–59 0.80 (0.69 to 0.92) 0.81 (0.70 to 0.93)
60–64 0.64 (0.56 to 0.74) 0.64 (0.55 to 0.74)
65–69 0.43 (0.37 to 0.50) 0.42 (0.36 to 0.49)
70–74 0.35 (0.30 to 0.41) 0.35 (0.29 to 0.41)
Practice IMD (per decile) 0.97 (0.95 to 0.98) <0.001 0.99 (0.92 to 1.07) 0.829
Sex
Female Reference 0.675 Reference 0.184
Male 0.98 (0.89 to 1.08) 0.94 (0.85 to 1.03)
Smoking status
Ex/non-smoker Reference <0.001 Reference <0.001
Current smoker 1.34 (1.18 to 1.51) 1.35 (1.19 to 1.54)
Practice (SD of random effect) 0.29 (0.18 to 0.49) <0.001
CVD, cardiovascular disease; IMD, Indices of Multiple Deprivation.
Table 3 OR of association of IMD and other variables on attendance at screening
Attendance at screening
(n=5466) Crude OR (95% CI) p Value Adjusted OR (95% CI) p Value
IMD (per decile) 0.87 (0.85 to 0.88) <0.001 0.89 (0.86 to 0.91) <0.001
Age
50–54 Reference 0.023 Reference 0.113
55–59 1.21 (1.04 to 1.40) 1.20 (1.03 to 1.40)
60–64 1.26 (1.09 to 1.46) 1.15 (0.99 to 1.35)
65–69 1.19 (0.99 to 1.41) 1.10 (0.91 to 1.32)
70–74 1.10 (0.90 to 1.35) 0.99 (0.80 to 1.23)
Practice IMD (per decile) 0.90 (0.88 to 0.91) <0.001 0.96 (0.88 to 1.05) 0.418
Sex
Female Reference <0.001 Reference <0.001
Male 0.70 (0.63 to 0.78) 0.75 (0.67 to 0.84)
Smoking status
Ex/non-smoker Reference <0.001 Reference <0.001
Current smoker 0.40 (0.35 to 0.47) 0.48 (0.42 to 0.56)
Practice (SD of random effect) 0.35 (0.20 to, 0.63) <0.001
IMD, Indices of Multiple Deprivation.
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This could be due to variation in the conduct of the
studies and the target population, making comparison
between studies difﬁcult. This study’s attendance rate of
42% sits well within this range. Our ﬁndings of non-
attendance at screening being associated with those at
higher risk, namely the most deprived, males and
smokers, are consistent with previous studies evaluating
local screening programmes, such as the OXCHECK
study.22 The association between non-attendance and
higher deprivation has been shown consistently in other
studies.23 24 Only Lambert et al25 did not ﬁnd this, but
their cohort contained only males, taken from the most
deprived area nationally at the time.
Comparison with national screening programmes
The association between non-attendance at screening
and the most deprived was not found in studies examin-
ing determinants of NHS Health Check coverage. This
was seen both at a local level in east London,26
Stoke-on-Trent27 and Ealing28 and nationally,29 30 with
one national study ﬁnding the opposite association of
increased coverage in more deprived PCTs (coefﬁcient=
−0.51 (95% CI −1.88 to 0.00) in the least deprived PCTs
compared with those with the most, p=0.035).30 These
ﬁndings could be explained by a number of methodo-
logical differences, such as targeting invites to those
likely to be at higher risk, by using routinely collected
data to estimate risk.26–28 It is not reported whether a
greater proportion of the most deprived was invited, so
intentional selection bias could have inﬂuenced the
ﬁndings. These studies assessing local uptake were per-
formed in deprived settings and examined the effect of
local rather than national deprivation groupings; hence,
the effect across the entire scale of deprivation may not
be evident. The studies assessing NHS Health Check
uptake at a national level used PCT30 or practice-level29
deprivation rather than deprivation of individuals, which
could result in a distortion of the effect of deprivation.
They also assessed coverage of the eligible population
rather than proportion of those invited. While this is a
suitable measure of assessment from a public health per-
spective, it fails to capture whether the lack of associ-
ation between deprivation and attending an NHS
Health Check is due to selection bias. Indeed, work
undertaken in Germany31 and Singapore32 33 has found
that screening attendance is better in the most afﬂuent
groups.
Strengths and limitations
A major strength of this study was that the study popula-
tion represented all national IMD deciles, allowing com-
parison to be made over the entire spectrum of
socioeconomic status. In addition, the screening was
administered and performed entirely by research staff,
ensuring that invitation method, availability of screening
appointments, setting and content of screening were
consistent across the entire study population. This would
reduce potential selection or observer bias when deliver-
ing the screening programme. However, it is interesting
to note that despite these controls, screening uptake still
varied markedly between practices, even after adjusting
for other factors.
The Framingham equation does not account for
deprivation and has been shown to underestimate CVD
risk for patients in the most deprived groups.34
Therefore, the true effect of deprivation may also have
been underestimated here. The effect of ethnicity could
not be accounted for in the regression model owing to
incomplete recording in the medical records. We ran a
sensitivity analysis including complete case ethnicity
codes and found this had no tangible effect on the
strength of associations. The absence of ethnicity record-
ing in medical records has been reported previously19 35
and is therefore a concern in many such studies.
Table 4 OR of association of IMD and other variables on being at high risk at screening
Likely to be found at high risk of CVD at screening clinic (n=2321)
Crude OR (95% CI) p Value Adjusted OR (95% CI) p Value
IMD (per decile) 1.08 (1.05 to 1.11) <0.001 1.09 (1.03 to 1.15) 0.004
Age
50–54 Reference <0.001 Reference <0.001
55–59 1.89 (1.44 to 2.49) 2.73 (1.99 to 3.73)
60–64 3.44 (2.64 to 4.47) 6.58 (4.80 to 9.04)
65–69 6.73 (4.97 to 9.11) 14.10 (9.80 to 20.27)
70–74 12.22 (8.49 to 17.58) 32.50 (21.19 to 49.85)
Practice IMD (per decile) 1.06 (1.03 to 1.09) <0.001 0.97 (0.91 to 1.04) 0.446
Sex
Female Reference <0.001 Reference <0.001
Male 4.44 (3.71 to 5.31) 6.79 (5.44 to 8.46)
Smoking status
Ex/non-smoker Reference <0.001 Reference <0.001
Current smoker 3.54 (2.75 to 4.55) 5.73 (4.17 to 7.87)
Practice (SD of random effect) 0.19 (0.08 to 0.43) <0.016
CVD, cardiovascular disease; IMD, Indices of Multiple Deprivation.
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Implications for practice and research
Current incentives in primary care focus on achieving
optimal management of those already known to be at
high risk of developing CVD. However, many people at
potentially high risk are not being routinely proﬁled in
primary care when the opportunity arises. Incentivising
general practices to identify and treat more of this group
may be one way of attaining better population-level
management.
While this study found that people in lower socio-
economic groups were more likely to have their CVD
risk factors recorded, we also found that attempts to
increase this proportion might lead to an exacerbation
of health inequalities, via the inverse care law, as screen-
ing is not reaching the people who need it most.36 37
This should be considered when designing and imple-
menting screening programmes such as the NHS Health
Check, as they are unlikely to reduce current health
inequalities without active steps to address this issue.
Future research should focus on how the delivery of
CVD screening can be tailored to ensure engagement of
socioeconomically deprived groups and people known
to have risk factors for CVD. Work with simulation
models suggests that targeted screening of deprived
communities and family members of patients with CVD
would be more cost-effective than mass screening.38
However, this approach has not been tested in a real-
world study. Opportunistic screening of deprived
patients when they present to primary care for other
reasons39 or screening in a community setting such as
religious or community centres,40 pharmacies41 and
using community-based, lay health trainer-led
approaches42 may be of value. Different approaches to
recruitment should be directly compared with each
other, in particular their impact on recruitment of socio-
economically deprived groups. One such trial is already
underway, which will compare the use of a standard
NHS Health Check invitation letter to (1) a question–
behaviour effect questionnaire prior to the standard
NHS Health Check invitation letter and (2) a ﬁnancial
incentive to complete the questionnaire.43
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